1. Home
  2. DNN vs RCUS Comparison

DNN vs RCUS Comparison

Compare DNN & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denison Mines Corp (Canada)

DNN

Denison Mines Corp (Canada)

HOLD

Current Price

$3.18

Market Cap

3.4B

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$23.81

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNN
RCUS
Founded
1954
2015
Country
Canada
United States
Employees
N/A
601
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.0B
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
DNN
RCUS
Price
$3.18
$23.81
Analyst Decision
Strong Buy
Buy
Analyst Count
1
10
Target Price
$6.50
$31.90
AVG Volume (30 Days)
21.5M
1.1M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$247,000,000.00
Revenue This Year
$403.36
N/A
Revenue Next Year
N/A
$45.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.51
$7.92
52 Week High
$4.43
$28.72

Technical Indicators

Market Signals
Indicator
DNN
RCUS
Relative Strength Index (RSI) 34.71 47.48
Support Level $2.56 $20.20
Resistance Level $3.36 $24.33
Average True Range (ATR) 0.19 1.16
MACD -0.07 -0.31
Stochastic Oscillator 9.55 29.34

Price Performance

Historical Comparison
DNN
RCUS

About DNN Denison Mines Corp (Canada)

Denison Mines Corp is engaged in uranium mining-related activities, including the acquisition, exploration, development, and mining of uranium-bearing properties, as well as the processing, sale, and investment in uranium. The company's key properties include Wheeler River, Waterbury Lake, McClean Lake, Midwest, and others. It operates through two segments: the Mining segment and the Corporate and Other segment. The majority of the company's revenue is generated from the Mining segment, which includes activities related to exploration, evaluation, and development, mining, milling (including toll milling), and the sale of mineral concentrates.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: